Ohio Already Survived One Carfentanil Wave. The White House Just Warned the Whole Country a Second One Is Here.

In July 2016, the medical examiner’s office in Summit County, Ohio counted 52 unexplained deaths in a single month where drug overdose was the suspected cause but the toxicology screens kept coming back wrong — the standard opioid panels weren’t catching whatever was actually killing people. What reference lab testing eventually found was carfentanil, a large-animal tranquilizer with roughly 10,000 times the potency of morphine, showing up in a human drug supply for the first time. By the end of that year Ohio alone had logged nearly 400 carfentanil-involved deaths. Then, over the following two years, it mostly disappeared — trafficking networks moved on, and by the time overdose deaths in Ohio started falling in the 2020s, carfentanil’s retreat was one of the reasons cited.

The federal government just told the country, in writing, that carfentanil didn’t disappear. It moved.

On September 15, the Office of National Drug Control Policy issued a formal Drug Threat Notice — a rarely-used designation meant to put medical, public health, and law enforcement communities on alert — naming three fentanyl analogues as an active and growing threat: carfentanil, fluorofentanyl, and methylfentanyl. According to CDC estimates cited in the notice, the three substances and their chemical variants have been tied to at least 12,500 deaths since 2023, with fluorofentanyl responsible for nearly 12,000 of them on its own. Carfentanil and fluorofentanyl were detected in 48 states in 2025; methylfentanyl in 36. This is not a regional Ohio story anymore. It’s a national one, and the geography in the 2026 notice looks a lot like what Summit County saw a decade ago, scaled up.

What these drugs actually are, in plain terms

Fentanyl itself is a synthetic opioid — meaning it’s built in a lab rather than extracted from a poppy — that binds to the same receptors in your brain and spinal cord that natural opioids do, just far more efficiently, which is why a dose measured in micrograms can be lethal. An “analogue” is a molecule chemists build by tweaking fentanyl’s structure slightly, sometimes to dodge a specific scheduling law, sometimes just because the modification makes it cheaper or easier to produce at scale. Carfentanil is the most extreme of the three named in this notice — a veterinary tranquilizer for elephants and other large animals, never intended for humans at any dose, roughly 100 times more potent than fentanyl itself. Fluorofentanyl and methylfentanyl are described as “as potent or more potent” than fentanyl — meaning a person who has built up tolerance to a fentanyl-adulterated supply can still be caught off guard, because these aren’t simply “more fentanyl.” Structurally, they’re different enough that the body doesn’t always respond the way tolerance would predict.

That distinction is the whole reason this notice exists. Drug Czar Sara Carter put it plainly in the announcement: “Drug traffickers continue to produce and smuggle deadly substances into the United States.” The framing is enforcement-focused, and enforcement is only half the story — the other half is what happens in the sixty seconds after someone finds a person who isn’t breathing.

The naloxone math has already changed once

Here’s the part that belongs in every first responder’s and every family member’s head, translated out of pharmacology: naloxone works by kicking an opioid off the receptor it’s sitting on and taking that spot itself, for a limited window of time — typically 30 to 90 minutes before it wears off and needs a repeat dose if the opioid is still circulating. Standard naloxone dosing was calibrated for heroin and, later, adjusted upward once fentanyl became dominant, because fentanyl’s grip on the receptor is tighter and needs more naloxone to dislodge. Carfentanil’s grip is tighter still. During the 2016 Ohio wave, EMS crews and family members using take-home naloxone kits routinely needed multiple doses — sometimes four or five — to reverse a single carfentanil overdose, a pattern the CDC documented in real time as the standard two-dose kits that had worked reliably against heroin started failing.

This is not a reason to hesitate before giving naloxone — give it, and give it again if the person doesn’t respond within two to three minutes, and call 911 either way. It is a reason every harm reduction program, every case manager, and every parent keeping naloxone at home should treat “extra doses on hand” as the current standard, not the paranoid one. ONDCP’s own recommendation in the September notice says exactly that: be prepared to use more than one dose, and don’t wait to call for help.

ONDCP’s own recommendation in the September notice says exactly that: be prepared to use more than one dose, and don’t wait to call for help.

If you’re a provider stocking naloxone for clients or a family, this is the week to check your supply against that new baseline — two doses per kit is what worked in 2019. It is not enough for what’s circulating in 2026.

The number that’s actually moving in the right direction — for now

None of this erases the genuinely good news buried in the same data. CDC’s rapid-release surveillance system currently projects 67,798 overdose deaths for the 12 months ending in March 2026 — a 12.3% decline from the same period a year earlier, and part of a longer slide down from the roughly 107,000 peak in 2023. That decline is real, and it deserves to be said plainly rather than buried under caveats: fewer people are dying than were dying two years ago, and harm reduction access, wider naloxone distribution, and expanded buprenorphine access all get real credit for that. The 2026 National Drug Control Strategy leans on that trend as evidence its approach is working.

But a national decline in total deaths is compatible with a dangerous new analogue climbing underneath it, the same way Ohio’s overall overdose numbers kept falling for years after 2018 even while carfentanil quietly stopped being an Ohio-only problem and became everyone’s problem. A supply that’s 12% safer on average and also capable of killing you eight times faster in a specific, undetectable pocket of it isn’t a contradiction. It’s exactly the pattern this notice is trying to name before it becomes the next Summit County — except this time, spread across 48 states instead of one.